Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human HLA-DPB1 Protein, N-His

Catalog #:   YHM01801 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P04440
Protein length: Asn35-Gln218
Overview

Catalog No.

YHM01801

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Asn35-Gln218

Predicted molecular weight

23.76 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P04440

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

HLA class II histocompatibility antigen, DP beta 1 chain, HLA class II histocompatibility antigen, DP(W4) beta chain, MHC class II antigen DPB1, HLA-DPB1, HLA-DP1B

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human HLA-DPB1 protein
References

The HLA-DPB1*1469:01 Allele Identified by Next-Generation Sequencing., PMID:40481802

Confirmation of HLA-II associations with TB susceptibility in admixed African samples., PMID:40458991

Characterisation of the Novel HLA-DPB1*29:01:02 Allele Using New Next-Generation Sequencing Methods., PMID:40434244

Characterisation of the HLA-DPB1*104:01:08 Allele by Sequencing-Based Typing., PMID:40371933

Identification of the Novel HLA-DPB1*1758:01 Allele by Pacbio Sequencing., PMID:40357900

Characterisation of the Novel HLA-DPB1*1783:01 Allele by Sequencing-Based Typing., PMID:40341853

The cancer stem cells characteristics analysis of LGR5 + cells that influence lung cancer risk by using single cell RNA-seq analysis., PMID:40341189

Identification of the Novel Allele HLA-DPB1*1782:01 in a Deceased Donor by Third-Generation Sequencing., PMID:40304361

Polymorphisms in HLA genes among Brazilian patients hospitalized with COVID-19: Insights from a multicentric study., PMID:40188974

Identification of DPB1*1608:01 by Next-Generation Sequencing in North Indian Individual., PMID:40160185

Characterisation of the Novel HLA-DPB1*1781:01 Allele Using Oxford Nanopore Sequencing Technology., PMID:40117129

HLA Association With AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder in the Korean Population., PMID:40020215

Characterisation of the Novel HLA-DPB1*04:02:27 Allele by Sequencing-Based Typing., PMID:39971726

Identification of Three Novel HLA Alleles: HLA-DPB1*1619:01, -DPB1*1621:01 and -DPB1*1737:01., PMID:39957276

Identification of the Novel HLA-DPB1*1483:01 Allele in a Deceased Hispanic/Latino Donor., PMID:39887958

RNAseq of peripheral blood mononucleated cells exposed to platelet-rich fibrin and enamel matrix derivatives., PMID:39881164

Identification of Two Novel HLA Class II Alleles, DPB1*1626:01Q and DRB1*11:337, by Next-Generation Sequencing., PMID:39865474

The Novel HLA-DPB1*1617:01 Allele Characterised by Two Different Sequencing-Based Typing Techniques., PMID:39823180

The Novel HLA-DPB1*1498:01 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual., PMID:39807670

The novel HLA-DPB1*05:01:23 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual., PMID:39789961

HLA typing in anti-GAD antibody associated epilepsy., PMID:39673990

Identification of the Novel HLA-DPB1*01:01:15 Allele by Next-Generation Sequencing., PMID:39663882

Identification of the Novel HLA-DPB1*03:01:27 Allele by Next-Generation Sequencing., PMID:39637334

Characterisation of the Novel HLA-DPB1*1641:01 Allele by Next-Generation Sequencing., PMID:39637333

The Novel HLA-DPB1*1327:01 Allele Identified by Next-Generation Sequencing in a Potential Haematopoietic Stem Cell Donor., PMID:39616541

Sarcoidosis in Beryllium Exposed Workers: A Case-Case Study., PMID:39584481

The Novel HLA-DPB1*05:01:22 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual., PMID:39532436

Novel HLA-DQB1, DQA1, DPA1 and DPB1 alleles identified in the Australian New South Wales tissue typing laboratory., PMID:39488996

Population genetic dissection of HLA-DPB1 amino acid polymorphism to infer selection., PMID:39413638

From clones to immunopeptidomes: New developments in the characterization of permissive HLA-DP mismatches in hematopoietic cell transplantation., PMID:39396259

[Sequence analysis and identification of a novel HLA-DPB1*02:01:69 allele by third-generation sequencing]., PMID:39344610

HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles., PMID:39306605

Characterisation of the novel HLA-DPB1*04:02:24 allele by next-generation sequencing., PMID:39279439

Hiding in plain sight: Misinterpretation of immunogenic DPB epitopes within G/P groups., PMID:39277973

Characterisation of the novel HLA-DPB1*1618:01 allele by sequencing-based typing., PMID:39234817

Identification of the novel HLA-DPB1*21:01:02 allele using nanopore sequencing technology., PMID:39219378

Genetic association of antinuclear antibodies with HLA in JIA patients: a Swedish cohort study., PMID:39187888

The novel HLA-DPB1*04:02:01:44 allele identified in a volunteer bone marrow donor., PMID:39171357

The characteristic of HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DRB3/4/5, HLA-DQA1, HLA-DQB1, HLA-DPA1, and HLA-DPB1 alleles in Zhejiang Han population., PMID:39107575

Identification of the novel HLA-DPB1*14:01:15 allele in a Brazilian bone marrow donor., PMID:39091266

Decoding the genetic landscape of juvenile dermatomyositis: insights from phosphorylation-associated single nucleotide polymorphisms., PMID:39085621

Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis., PMID:39030878

Association between specific human leukocyte antigen alleles and development of thyroid immune-related adverse event., PMID:38889451

HLA-DPB1 and DPA1 ~ DPB1 linkage mismatch affects the survival of recipients receiving HLA-14/14 matched unrelated donor HSCT., PMID:38887889

The novel HLA-DPB1*1553:01 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual., PMID:38887192

Homozygosity in any HLA locus is a risk factor for specific antibody production: the taboo concept 2.0., PMID:38840925

Identification of the novel HLA-DPB1*1591:01 allele by next-generation sequencing., PMID:38812465

Polymorphisms of HLA genes and hypersensitivity to penicillin among patients in a Taiwanese population., PMID:38741273

The novel HLA-DPB1*05:01:20 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual., PMID:38699836

Characterisation of the novel HLA-DPB1*1437:01 and HLA-DPB1*1438:01 alleles by next-generation sequencing., PMID:38634571

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human HLA-DPB1 Protein, N-His [YHM01801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only